Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2922-2026Class II

Surgipro II S8698GX SURGIPRO II BL 5/0 18 P-13 S8698GX

Medtronic, Inc. / initiated 2026-06-24 / Open, Classified / root cause: manufacturing process

Covidien, LP began a recall of Surgipro II S8698GX SURGIPRO II BL 5/0 18 P-13 S8698GX on . FDA classified it as Class II and gives the reason as "Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2922-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Medtronic, Inc.
Product
Surgipro II S8698GX SURGIPRO II BL 5/0 18 P-13 S8698GX
Product code
GAW Suture, Nonabsorbable, Synthetic, Polypropylene
Reason for recall
Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.
Root cause tag
manufacturing process
FDA root cause
Equipment maintenance
Action
The firm began notifying consignees on 7/7/26 via email, mail, or electronically. Notices were titled, "URGENT: VOLUNTARY MEDICAL DEVICE RECALL." Customers were informed of the manufacturing nonconformance. If products in scope of this field action have been used in patients under the customer's care, the customer is instructed to monitor for signs of infection or vision issues due to the possibility of biocontamination. Customers were instructed to immediately identify, cease use, and quarantine all unused impacted product. Unused impacted product is to be returned to Medtronic. The recall notice should be passed on to all those who need to be aware within the customer's organization or to any organization where devices have been transferred.
Quantity in commerce
135,875 total
Distribution
US Nationwide and the countries of Australia, Austria, Belgium, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Guadeloupe, Guatemala, Honduras, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Kosovo, Lebanon, Lithuania, Luxembourg, Mexico, Namibia, Netherlands, North Macedonia, Northern Ireland, Norway, Oman, Panama, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan.
Product codes and lots
S8698GX UDI-DI 20612479214716 Lot D5M3438FY

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2922-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2918-2026Class IIOngoingVoluntary: Firm initiated
Z-2919-2026Class IIOngoingVoluntary: Firm initiated
Z-2920-2026Class IIOngoingVoluntary: Firm initiated
Z-2921-2026Class IIOngoingVoluntary: Firm initiated
Z-2922-2026Class IIOngoingVoluntary: Firm initiated